HARP
Harpoon Therapeutics Inc
Price:  
23.01 
USD
Volume:  
6,569,730.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HARP WACC - Weighted Average Cost of Capital

The WACC of Harpoon Therapeutics Inc (HARP) is 6.7%.

The Cost of Equity of Harpoon Therapeutics Inc (HARP) is 9.75%.
The Cost of Debt of Harpoon Therapeutics Inc (HARP) is 5.00%.

Range Selected
Cost of equity 7.90% - 11.60% 9.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 7.6% 6.7%
WACC

HARP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.88 1.2
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 11.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 7.6%
Selected WACC 6.7%